Interaction between ITGA4 in melanoma cells and VCAM‐1 on activated endothelial cells enhances the metastatic capacity of melanoma cells 39, and inhibition of ITGA4 in MV3 melanoma cells with non‐anticoagulant heparin derivatives attenuates melanoma metastatic potential 40. The gene discussed is VCAM1; the disease is melanoma.